An experimental and computational study to evaluation of chitosan/gum tragacanth coated-natural lipid-based nanocarriers for sunitinib delivery
Authors:
- Salar KhaledianSKSalar Khaledian
- Danial KahriziDKDanial Kahrizi
- Sajad MoradiSMSajad Moradi
- Fleming MartinezFleming Martinez
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 334
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Multifunctional nanoparticles as biocompatible targeted probes for human cancer diagnosis and therapyJournal of Materials Chemistry, 2009
- Nanotechnology-based drug delivery systemsJournal of Occupational Medicine and Toxicology, 2007
- Molecular Dynamics Simulations of Lipid Vesicle Fusion in Atomic DetailBiophysical Journal, 2007
- Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell CarcinomaClinical Cancer Research, 2007
- Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell CarcinomaThe Oncologist, 2007
- Sunitinib malate for the treatment of solid tumours: a review of current clinical dataExpert Opinion on Investigational Drugs, 2006
- Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell lineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJournal of Controlled Release, 1994